Logo
x

Search

Subscribe Now

scholar rock

Scholar Rock Reports the US FDA's BLA Submission for Apitegromab to Treat Spinal Muscular Atrophy (SMA)

Scholar Rock Reports the US FDA's BLA Submission for Apitegromab to Treat Spinal Muscular Atrophy (SMA)

  • January 30, 2025
Nagesh Mahanthappa, Interim CEO of Scholar Rock Shares Insights on Treatment Options for Spinal Muscular Atrophy

Nagesh Mahanthappa, Interim CEO of Scholar Rock Shares Insights on Treatment Options for Spinal Muscular Atrophy

  • October 3, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.